What medicines are available for psychedelic therapy?

Ketamine is prescribed off-label and has been described as psychedelic in the sub-anesthetic mental health and pain management treatment range. Other molecules are less accessible, and research is ongoing.
What medicines are available for psychedelic therapy?

There are many molecules being studied in mental health. The FDA is currently considering new drug applications for patented versions of Ketamine, MDMA, Esketamine, Psilocybin, LSD, DMT. Many of these have been noted as "Priority Review". Research into these generic compounds extends over 100 years, with early research studying the effects of mescaline in indigenous plant-medicine practitioners of the desert Southwest on the body and mind.

The experience that accompany these molecules was labeled "psychedelic" in the 1950's, which has become the umbrella term for the experience and after-effects of ingesting these compounds. Pharmaceutical companies are studying patented forms of these drug compounds to produce and sell at scale for profit. Many of these molecules are found in their whole forms in nature.

These and other plant-based or synthetic compounds may be combined in ways that may or may not elicit any associated experience.

You are not just a meat bag of chemicals. You are a meat bag of chemicals having an experience.

Psychedelic Cognitive Behavioral Therapy: On Ketamine, Context and Competencies in “Assisted-Psychotherapy”
There are many tools to help a psychotherapist help clients learn to speak the language of cognitive behavioral therapy, especially tools which may help facilitate therapeutic alliance, including, but not limited to telehealth.

Psychedelics open a new window on the mechanisms of perception
Some neuroscientists think psychedelic drugs and the hallucinations they induce could help reveal how the brain generates our perceptions of the world around us — and of ourselves
Post by @PsychedelicInstitute@mastodon.social
View on Mastodon

Ketamine for the Treatment of Psychiatric Disorders: A Systematic Review and Meta-Analysis | CNS Spectrums | Cambridge Core
Ketamine for the Treatment of Psychiatric Disorders: A Systematic Review and Meta-Analysis - Volume 29 Issue 5

"Inadequate response to first- and second-line pharmacological treatments for psychiatric disorders is commonly observed. Ketamine has demonstrated efficacy in treating adults with treatment-resistant depression (TRD), with additional off-label benefits reported for various psychiatric disorders. Extant literature supports the potential use of ketamine for the treatment of PTSD, OCD, and alcohol use disorders with significant improvement of patient symptoms."

Cognitive Behavioral Mental Health & Psychedelics
Ketamine, Esketamine and Psychedelic Medicine Preparation, Support & Integration
Mastodon Mastodon